Related Experiment Video
Updated: May 18, 2026

Modeling Mitochondrial Disease Using Brain Organoids: A Focus on Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-like Episodes
Published on: October 10, 2025
Refractory epilepsy and mitochondrial dysfunction due to GM3 synthase deficiency
Konstantina Fragaki1, Samira Ait-El-Mkadem, Annabelle Chaussenot
1Department of Medical Genetics, National Center for Mitochondrial diseases, Nice Teaching Hospital, Nice, France.
Insights
GM3 synthase deficiency causes early-onset epilepsy by disrupting ganglioside synthesis, leading to secondary mitochondrial dysfunction. This highlights the importance of recognizing secondary mitochondrial disorders in metabolic diseases.
Area of Science:
- Biochemistry
- Genetics
- Neuroscience
Background:
- GM3 synthase is crucial for complex ganglioside synthesis.
- GM3 synthase deficiency is linked to neurological disorders.
Observation:
- Two children with early-onset epilepsy, developmental delay, failure to thrive, blindness, and deafness were studied.
- Fibroblast and liver analyses revealed respiratory chain (RC) dysfunction.
- Exome sequencing identified a homozygous nonsense mutation in the GM3 synthase gene.
Findings:
- Complete absence of GM3 ganglioside led to upregulation of the globoside pathway.
- Accumulation of Gb3 and Gb4 globosides correlated with RC dysfunction and decreased mitochondrial membrane potential.
- GM3 synthase deficiency was shown to cause secondary RC dysfunction.
Implications:
- This study reveals GM3 synthase deficiency as a cause of early-onset epilepsy syndrome.
- It underscores the significance of secondary mitochondrial disorders in diagnosing and managing metabolic diseases.
- Understanding this pathway is vital for developing therapeutic strategies for related neurological conditions.
Abstract:
We report two children, born from consanguineous parents, who presented with early-onset refractory epilepsy associated with psychomotor delay, failure to thrive, blindness and deafness. Polarographic and spectrophotometric analyses in fibroblasts and liver revealed a respiratory chain (RC) dysfunction. Surprisingly, we identified a homozygous nonsense mutation in the GM3 synthase gene by using exome sequencing. GM3 synthase catalyzes the formation of GM3 ganglioside from lactosylceramide, which is the first step in the synthesis of complex ganglioside species. Mass spectrometry analysis revealed that the complete absence of GM3 ganglioside and its biosynthetic derivatives was associated with an upregulation of the alternative globoside pathway in fibroblasts. The accumulation of Gb3 and Gb4 globosides likely has a role in RC dysfunction and in the decrease of mitochondrial membrane potential leading to apoptosis, which we observed in fibroblasts. We show for the first time that GM3 synthase deficiency, responsible for early-onset epilepsy syndrome, leads to a secondary RC dysfunction. Our study highlights the role of secondary mitochondrial disorders that can interfere with the diagnosis and the evolution of other metabolic diseases.
More Related Videos
09:40Phosphorus-31 Magnetic Resonance Spectroscopy: A Tool for Measuring In Vivo Mitochondrial Oxidative Phosphorylation Capacity in Human Skeletal Muscle
Published on: January 19, 2017
08:48Using Live Cell STED Imaging to Visualize Mitochondrial Inner Membrane Ultrastructure in Neuronal Cell Models
Published on: June 30, 2023
Related Concept Videos
Inborn Errors of Metabolism
Hepatic Encephalopathy
Antiepileptic Drugs: Glutamate Antagonists
Antiepileptic Drugs: GABAergic Pathway Potentiators
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...
Epilepsy and Seizures: Overview
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
ATP Synthase: Mechanism